Drug has 'very good chance of being game-changing in the clinic,' says researcher

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia

Drug has 'very good chance of being game-changing in the clinic,' says researcher